HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company has ...
HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, announced today that the company’s ...
We recently compiled a list of 10 Most Undervalued Healthcare Stocks to Buy According to Analysts. Bio-Rad Laboratories, Inc. stands tenth on our list and is currently making waves for launching a new ...
Earnings Call Insights: Bio-Rad Laboratories, Inc. (BIO) Q1 2025 CEO Norman Schwartz noted that despite macroeconomic headwinds, the company is focusing on long-term opportunities in life science ...
As Bio-Rad navigates the challenging funding environment in life sciences while capitalizing on opportunities in clinical diagnostics, investors will be watching closely to see if the company can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results